Results
1 -
5 of
5
(Click
here to explore results)
- Drug Transporters: Volume 1: Role and Importance in ADME and Drug Development, Chapter 11 Transporter Drug–Drug Interactions: Regulatory Requirements and Drug Labelling. Susan M. Cole, Gustav Ahlin, Naomi Nagai, Daisuke Iwata, Masanobu Sato, Kenta Yoshida
, 2016
, Volume 1
, Pages 418-449
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 4 (Benz)imidazoles. Roland Pfau
, 2016
, Pages 98-114
- Drug Transporters: Volume 1: Role and Importance in ADME and Drug Development, Chapter 10 Transporter Drug–Drug Interactions: A Pharmaceutical Industry Perspective. Silke Simon, Mohammed Ullah, Robert van Waterschoot, Dietmar Schwab, Susan Grange, Caroline A. Lee, Christoph Funk
, 2016
, Volume 1
, Pages 361-417
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Subject Index
, 2016
, Pages 459-468
- Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs. Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163